Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
SAN JOSE, Calif., Nov. 22, 2024 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Board of Directors has approved the purchase of Bitcoin as a treasury reserve asset. With Anixa’s strong balance sheet and excess cash, this…